TFEB and Hepatic fibrosis: Consistent with our hypothesis, studies in atherosclerosis and liver fibrosis have indicated that increased TFEB expression abrogates macrophage apoptosis and decreases proinflammatory cytokine levels, which reduces atherosclerosis plaque formation or fibrogenesis [20,24,52].